4-47320202-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_000812.4(GABRB1):c.537C>A(p.Ile179=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.188 in 1,579,056 control chromosomes in the GnomAD database, including 29,642 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2389 hom., cov: 32)
Exomes 𝑓: 0.19 ( 27253 hom. )
Consequence
GABRB1
NM_000812.4 synonymous
NM_000812.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0820
Genes affected
GABRB1 (HGNC:4081): (gamma-aminobutyric acid type A receptor subunit beta1) The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes GABA A receptor, beta 1 subunit. It is mapped to chromosome 4p12 in a cluster comprised of genes encoding alpha 4, alpha 2 and gamma 1 subunits of the GABA A receptor. Alteration of this gene is implicated in the pathogenetics of schizophrenia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BP6
Variant 4-47320202-C-A is Benign according to our data. Variant chr4-47320202-C-A is described in ClinVar as [Benign]. Clinvar id is 1573985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.082 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.204 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRB1 | NM_000812.4 | c.537C>A | p.Ile179= | synonymous_variant | 5/9 | ENST00000295454.8 | NP_000803.2 | |
GABRB1 | XM_024453976.2 | c.438C>A | p.Ile146= | synonymous_variant | 5/9 | XP_024309744.1 | ||
GABRB1 | XM_024453977.2 | c.438C>A | p.Ile146= | synonymous_variant | 6/10 | XP_024309745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRB1 | ENST00000295454.8 | c.537C>A | p.Ile179= | synonymous_variant | 5/9 | 1 | NM_000812.4 | ENSP00000295454 | P1 | |
GABRB1 | ENST00000510909.1 | c.*205C>A | 3_prime_UTR_variant, NMD_transcript_variant | 4/5 | 4 | ENSP00000426766 |
Frequencies
GnomAD3 genomes AF: 0.172 AC: 26172AN: 152016Hom.: 2392 Cov.: 32
GnomAD3 genomes
AF:
AC:
26172
AN:
152016
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.170 AC: 42605AN: 251052Hom.: 4036 AF XY: 0.170 AC XY: 23073AN XY: 135684
GnomAD3 exomes
AF:
AC:
42605
AN:
251052
Hom.:
AF XY:
AC XY:
23073
AN XY:
135684
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.190 AC: 271421AN: 1426922Hom.: 27253 Cov.: 28 AF XY: 0.188 AC XY: 133974AN XY: 712108
GnomAD4 exome
AF:
AC:
271421
AN:
1426922
Hom.:
Cov.:
28
AF XY:
AC XY:
133974
AN XY:
712108
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.172 AC: 26169AN: 152134Hom.: 2389 Cov.: 32 AF XY: 0.171 AC XY: 12724AN XY: 74364
GnomAD4 genome
AF:
AC:
26169
AN:
152134
Hom.:
Cov.:
32
AF XY:
AC XY:
12724
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
433
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 15, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 28% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 26. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at